Treatment of Corneal Abrasions

First-Line Treatment Options

Topical broad-spectrum antibiotics are the first-line treatment for corneal abrasions to prevent secondary bacterial infection, as recommended by medical guidelines 1, 2
Fluoroquinolones, such as moxifloxacin or gatifloxacin, are preferred due to their broad-spectrum coverage and FDA approval for bacterial keratitis treatment 2
For non-contact lens wearers with simple abrasions, antibiotic drops alone are typically sufficient 2
Antibiotic ointment may be used at bedtime for additional protection and lubrication 2
Chloramphenicol ointment has been shown to be effective in preventing corneal ulcers when applied within 48 hours of corneal abrasion 3

Apply topical antibiotic drops, with fluoroquinolones preferred, 4 times daily for simple, non-contact lens related abrasions 2
Consider antibiotic ointment at bedtime for additional protection in simple, non-contact lens related abrasions 2
Pain control with oral analgesics, such as acetaminophen or NSAIDs, is recommended 1
Avoid contact lens wear until complete healing is confirmed for contact lens related abrasions 1
Do not use eye patches in contact lens wearers due to increased risk of bacterial keratitis 1

Patching is not recommended as it does not improve pain and may delay healing 2
Topical steroids should be avoided initially as they may delay healing and increase infection risk 2
Prophylactic antibiotics are most effective when started within 24 hours of the abrasion 1
Chronic use of prophylactic antibiotics may promote resistant organisms 2

Rubbing the eye can worsen the injury and potentially cause further damage 1
Warning signs requiring immediate care include increasing pain, purulent discharge, corneal infiltrate, or vision loss 2
Inadequate blinking or incomplete eyelid closure can delay healing 2

Chloramphenicol ointment 1% three times daily for 3 days is effective when started within 48 hours of injury in non-contact lens wearers, according to the American Academy of Ophthalmology 4

For persistent epithelial defects, consider oral doxycycline, autologous serum, or amniotic membrane application, as recommended by the American Academy of Ophthalmology 5